(Q55475600)

12 July 2018

title

Prognostic factors for medulloblastoma. (English)

1 reference

12 July 2018

0 references

Jenkin D

1

1 reference

12 July 2018

Shabanah MA

2

1 reference

12 July 2018

Shail EA

3

1 reference

12 July 2018

Gray A

4

1 reference

12 July 2018

Hassounah M

5

1 reference

12 July 2018

Khafaga Y

6

1 reference

12 July 2018

Kofide A

7

1 reference

12 July 2018

Mustafa M

8

1 reference

12 July 2018

Schultz H

9

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

12 July 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

12 July 2018

volume

47

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

573-584

1 reference

12 July 2018

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Treatment results for 149 medulloblastoma patients from one institution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Radiation treatment for medulloblastoma. A 21-year review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma: Treatment technique and radiation dosimetry

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma: is the 5-year survival rate improving? A review of 80 cases from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

The change in patterns of relapse in medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Microscopic local leptomeningeal invasion at diagnosis of medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Influence of a child's sex on medulloblastoma outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma: differences in adults and children--regarding Frost et al., IJROBP 32:951-957; 1995 and Prados et al., IJROBP 32:1145-1152; 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Subsequent quality of life for children irradiated for a brain tumor before age four years.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Risk factors of recurrence in 157 MB/PNET patients treated in one institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Childhood medulloblastoma in Ontario, 1977-1987: population-based results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

The radiation treatment of medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900431-4

7 January 2021

10.1016/S0360-3016(00)00431-4

Identifiers

DOI

1 reference

12 July 2018

PubMed ID

10837938

1 reference

12 July 2018